Brevan Howard Capital Management LP Increases Stake in Delek US Holdings, Inc. (NYSE:DK)

Brevan Howard Capital Management LP grew its stake in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) by 266.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 37,138 shares of the oil and gas company's stock after purchasing an additional 26,998 shares during the quarter. Brevan Howard Capital Management LP owned approximately 0.06% of Delek US worth $687,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Ion Asset Management Ltd. lifted its stake in Delek US by 16.5% in the fourth quarter. Ion Asset Management Ltd. now owns 3,455,000 shares of the oil and gas company's stock worth $63,918,000 after acquiring an additional 488,509 shares during the period. Barclays PLC lifted its stake in Delek US by 23.1% in the fourth quarter. Barclays PLC now owns 1,842,035 shares of the oil and gas company's stock worth $34,078,000 after acquiring an additional 345,210 shares during the period. Northern Trust Corp lifted its stake in Delek US by 8.0% in the fourth quarter. Northern Trust Corp now owns 903,840 shares of the oil and gas company's stock worth $16,721,000 after acquiring an additional 66,815 shares during the period. Ameriprise Financial Inc. lifted its stake in Delek US by 14.4% in the fourth quarter. Ameriprise Financial Inc. now owns 792,111 shares of the oil and gas company's stock worth $14,654,000 after acquiring an additional 99,521 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in Delek US by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 766,807 shares of the oil and gas company's stock worth $14,186,000 after acquiring an additional 45,017 shares during the period. Hedge funds and other institutional investors own 97.01% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. Wells Fargo & Company dropped their price target on Delek US from $16.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, April 16th. Piper Sandler lowered their price objective on Delek US from $18.00 to $17.00 and set a "neutral" rating for the company in a research report on Friday, March 7th. Scotiabank lowered their price objective on Delek US from $24.00 to $14.00 and set a "sector perform" rating for the company in a research report on Friday, April 11th. Raymond James lowered their price objective on Delek US from $24.00 to $23.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Finally, Mizuho raised Delek US from a "neutral" rating to an "outperform" rating and raised their price objective for the company from $22.00 to $23.00 in a research report on Tuesday. Five equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $17.02.

Insider Activity at Delek US

In other news, CFO Mark Wayne Hobbs bought 2,800 shares of Delek US stock in a transaction that occurred on Tuesday, March 11th. The stock was bought at an average cost of $13.70 per share, with a total value of $38,360.00. Following the acquisition, the chief financial officer now owns 49,138 shares of the company's stock, valued at $673,190.60. The trade was a 6.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders purchased 5,055 shares of company stock worth $70,787. 1.80% of the stock is owned by company insiders.

Delek US Stock Performance

NYSE DK traded up $0.20 during trading hours on Wednesday, hitting $17.53. The company's stock had a trading volume of 823,146 shares, compared to its average volume of 1,249,699. Delek US Holdings, Inc. has a 12 month low of $11.03 and a 12 month high of $28.91. The company's 50 day simple moving average is $14.18 and its two-hundred day simple moving average is $16.61. The company has a market cap of $1.06 billion, a P/E ratio of -3.61 and a beta of 0.74. The company has a debt-to-equity ratio of 3.18, a current ratio of 1.04 and a quick ratio of 0.67.

Delek US (NYSE:DK - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) EPS for the quarter, missing the consensus estimate of ($2.27) by ($0.05). Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. The business had revenue of $2.64 billion for the quarter, compared to analysts' expectations of $2.56 billion. During the same period in the previous year, the company earned ($0.41) EPS. Delek US's revenue for the quarter was down 18.1% compared to the same quarter last year. As a group, sell-side analysts expect that Delek US Holdings, Inc. will post -5.5 EPS for the current fiscal year.

Delek US Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, May 19th. Stockholders of record on Monday, May 12th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 5.82%. The ex-dividend date of this dividend is Monday, May 12th. Delek US's dividend payout ratio (DPR) is currently -9.18%.

About Delek US

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.